Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) EPS (Basic) (2022 - 2026)

Core Laboratories filings provide 5 years of EPS (Basic) readings, the most recent being -$0.02 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 1455.74% to -$0.02 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.63, a 3.28% increase, with the full-year FY2025 number at $0.65, down 2.99% from a year prior.
  • EPS (Basic) hit -$0.02 in Q1 2026 for Core Laboratories, down from $0.11 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.49 in Q2 2023 to a low of -$0.02 in Q1 2026.
  • Median EPS (Basic) over the past 5 years was $0.16 (2024), compared with a mean of $0.16.
  • Biggest five-year swings in EPS (Basic): skyrocketed 226.67% in 2023 and later crashed 1455.74% in 2026.
  • Core Laboratories' EPS (Basic) stood at $0.14 in 2022, then crashed by 64.29% to $0.05 in 2023, then surged by 220.0% to $0.16 in 2024, then tumbled by 31.25% to $0.11 in 2025, then tumbled by 118.18% to -$0.02 in 2026.
  • The last three reported values for EPS (Basic) were -$0.02 (Q1 2026), $0.11 (Q4 2025), and $0.31 (Q3 2025) per Business Quant data.